Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (168)	1/10/1999 4:19:00 PM
From: WWS	Read Replies (1) \| Respond to of 805

Miljenko, glad to see you over here. I got into CTII about 2 months ago, and also into VMRX about same time, another stem cell company. I noted your concerns about ethics of CTII's use of placebo control group for its Phase II study. Since proposed study had to go through at least one (probably more) Institutional Review Boards they probably addressed your concerns. Generally approval is granted for research studies if health of placebo group is not threatened by withholding of active treatment, and also if active treatment is made available to the placebo group once study is over. Both of these conditions seem to have been met in this study. Thanks again for all the information you provided to me about possible new treatments for ovarian cancer. My friend is still doing well now, approximately 20 months post-operative (ovarian epithelial stage 4 cancer) and after standard chemo w/cisplat and tamoxifen. Bill.

To: Miljenko Zuanic who wrote (168)	1/11/1999 3:42:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 805

I understand what you are saying about placebo group...I once saw something where the placebo group got a small scalpel slash and then bandage, with a full surgical simulation...only all phony, yikes. Here is a post I left over on the yahoo thread...just fluffy stuff, nothing with too much bearing on ctii, just a link to an article etc. post.messages.yahoo.com@m2.yahoo.com hmmm, I checked the link and nothing there, so here is the post--Yahoo certainly does not seem to be very stable sometimes. Found this on medscape "If these new neurons are functional, stem cells in areas of the brain damaged by neurodegenerative disorders or ischemic injury can be recruited to form new neurons." medscape.com You will need to have a login ID etc but if not...Clinical Psychiatry News 26(12):23, 1998. Also, I noticed the other day that Mark Levin, the CEO of Millenium is on the board of directors of CTII. I think that is a plus.